Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012

David Brindley,Natasha L. Davie,William A. Sahlman,Gregory A. Bonfiglio,Emily J. Culme-Seymour,Brock Reeve,Chris Mason

Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012

2012

David Brindley
Natasha L. Davie
William A. Sahlman
Gregory A. Bonfiglio
Emily J. Culme-Seymour
Brock Reeve
Chris Mason

In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.

Keywords:

Quarter (United States coin)
Clinical trial
Cell biology
Biotechnology
Cell therapy
Biology
capital investment
Genetics
Monetary economics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations